GENOMIC VISION This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Genomic Vision specializes in developing genetic diseases diagnosis tests and cancer genomic analysis. The group uses molecular combing technology which allows direct visualization of DNA individual molecules in order to detect the quantitative and qualitative changes of the genome and determine their role in targeted pathology. The activity is organized around 3 sources of income:
- sales of equipment and consumables: to academic laboratory centers using the molecular combing technology for research purposes;
- license and royalties income: income from collaboration with Quest Diagnostics;
- sales of software, testing kits and related consumables.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.12% | 42.59B | |
| +6.77% | 40.65B | |
| +46.73% | 40.57B | |
| -11.96% | 26.77B | |
| +6.01% | 24.81B | |
| -24.92% | 18.17B | |
| -3.63% | 11.7B | |
| +27.16% | 12.05B | |
| +7.30% | 11.1B |
